01 4Boehringer Ingelheim (Canada) Ltd.
01 22557801
02 22606650
01 4EMPAGLIFLOZIN
01 4TABLET
01 22025-03-11
02 22026-05-02
Patent Expiration Date : 2025-03-11
Date Granted : 2013-06-25
Brand Name : JARDIANCE
Patent Number : 2557801
Filing Date : 2005-03-11
Strength per Unit : 10 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2025-03-11
Date Granted : 2013-06-25
Patent Expiration Date : 2026-05-02
Date Granted : 2014-02-11
Brand Name : JARDIANCE
Patent Number : 2606650
Filing Date : 2006-05-02
Strength per Unit : 10 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-05-02
Date Granted : 2014-02-11
Patent Expiration Date : 2026-05-02
Date Granted : 2014-02-11
Brand Name : JARDIANCE
Patent Number : 2606650
Filing Date : 2006-05-02
Strength per Unit : 25 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-05-02
Date Granted : 2014-02-11
Patent Expiration Date : 2025-03-11
Date Granted : 2013-06-25
Brand Name : JARDIANCE
Patent Number : 2557801
Filing Date : 2005-03-11
Strength per Unit : 25 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2025-03-11
Date Granted : 2013-06-25
